Will any clinical trial on STAR-T cell immunotherapy in solid tumors be announced in 2023?
3
110Ṁ85resolved Jan 20
Resolved
NO1H
6H
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Name | Total profit |
|---|---|---|
| 1 | Ṁ36 | |
| 2 | Ṁ8 |
People are also trading
Will tabernanthalog (TBG) undergo Stage II clinical trials by EOY 2026?
41% chance
Will cevumeran start a Phase III trial for pancreatic cancer by 2030?
57% chance
Which immunotherapy companies will be around in 2028?
Will someone use STEMCELL or bit.bio technology for their regeneron STS project in 2025
52% chance
Will I get follistatin gene therapy by EOY 2026?
35% chance
Will an mRNA vaccine for cancer be available by 2024?
7% chance
Will a cancer therapy approved by the FDA before 2027 successfully cure >1 cancer type?
63% chance
Will AOH1996 advance past Phase II trials by the end of 2027?
43% chance
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
21% chance
Will a novel therapeutic/device which confers a survival benefit for glioblastoma be FDA approved by EOY 2028?
51% chance
Sort by:
@traders Any proof of YES before this resolves NO? I could find no proof of such specific trial in all my research.
People are also trading
Related questions
Will tabernanthalog (TBG) undergo Stage II clinical trials by EOY 2026?
41% chance
Will cevumeran start a Phase III trial for pancreatic cancer by 2030?
57% chance
Which immunotherapy companies will be around in 2028?
Will someone use STEMCELL or bit.bio technology for their regeneron STS project in 2025
52% chance
Will I get follistatin gene therapy by EOY 2026?
35% chance
Will an mRNA vaccine for cancer be available by 2024?
7% chance
Will a cancer therapy approved by the FDA before 2027 successfully cure >1 cancer type?
63% chance
Will AOH1996 advance past Phase II trials by the end of 2027?
43% chance
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
21% chance
Will a novel therapeutic/device which confers a survival benefit for glioblastoma be FDA approved by EOY 2028?
51% chance